top of page
Search
AI Is Approaching Its First Peak—Not Its Destination.Tim Draper’s perspective on the technology curve, AI infrastructure, and the next era of innovation
SaniMed Science Group recently participated in Founder Institute’s global Venture Trailblazers event featuring Silicon Valley venture capitalist Tim Draper. The online session, hosted by Adeo Ressi, Founder of Founder Institute, brought together more than 1,000 founders, investors, and innovators from around the world.
5 days ago4 min read
SaniMed Science Group Participates in TEN Capital Investor Education Series and Explores Follow-Up Opportunities with Emerging Healthcare Startups
July 7, 2026 — SaniMed Science Group Founder and CEO Jim Wu, M.D., MBA, participated as an investor panelist in the TEN Capital Investor Education Series, providing feedback to four emerging companies across medical technology, precision diagnostics, consumer wellness, and health-focused food innovation.
Jul 154 min read
BLPN China Access Panel Highlights Cross-Border Life Science Collaboration During BIO Week 2026
San Diego, California — June 23, 2026 — During BIO Week 2026, the BLPN China Access Panel, organized in collaboration with SaniMed Science Group, brought together senior life science executives, investors, regulatory experts, and cross-border business development leaders for a timely discussion on how global biopharma innovation can better connect with China’s rapidly evolving healthcare ecosystem.
Jul 35 min read
Advancing AI-Driven Innovation in Pharma, Biotech, and MedTech —— Reflections on Completing the MIT Sloan Executive Program
SaniMed Science Group shares insights following Founder Jim Wu, M.D., MBA’s completion of the MIT Sloan Executive Program in Artificial Intelligence in Pharma and Biotech. The program deepened strategic understanding of AI-driven discovery, clinical development, regulatory readiness, and commercialization, reinforcing SaniMed’s mission to accelerate global MedTech and Biotech innovation across the U.S., China, and Europe through responsible, scalable AI solutions.
Nov 17, 20252 min read
SaniMed Science Group Founder Jim Wu Joins Bullpen Inviting You to Co-Build a New Platform for Cross-Border Healthcare Innovation
Jim Wu, M.D., MBA, Founder of SaniMed Science Group and Chairman of BioTech (Shanghai), has joined the U.S.-based Bullpen Club as a Lifetime Founder Member and Money Ball Program Coach. Leveraging nearly 30 years of experience in biotech, MedTech, AI healthcare, and cross-border investment, he will help connect Chinese and Asian healthcare innovators with global capital, strategic partners, and international acceleration platforms to advance global commercialization and colla
Nov 8, 20253 min read
bottom of page